Journal article icon

Journal article

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial

Abstract:

Background: There has been a significant change in trials methodology for solid tumours, in response to our greater understanding of cancer biology. FOCUS4 is a phase II/III trial programme testing targeted agents in patients with advanced colorectal cancer (CRC) in molecularly stratified cohorts. Here we p...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's Version

Actions


Access Document


Files:
Publisher copy:
10.1016/S2468-1253(17)30394-1

Authors


Expand authors...
More from this funder
Grant:
*Grant Number Example*
Expand funders...
Publisher:
Elsevier Publisher's website
Journal:
Lancet Gastroenterology and Hepatology Journal website
Volume:
3
Issue:
3
Pages:
162-171
Publication date:
2017
Acceptance date:
2017-11-09
DOI:
EISSN:
2468-1253
Pubs id:
pubs:744823
URN:
uri:02cda4d2-7789-4372-ad71-dd4145a107be
UUID:
uuid:02cda4d2-7789-4372-ad71-dd4145a107be
Local pid:
pubs:744823

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP